Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
Abstract Vaccination can prevent viral infections via virus-specific T cells, among other mechanisms. A goal of oncolytic virotherapy is replication of oncolytic viruses (OVs) in tumors, so pre-existing T cell immunity against an OV-encoded transgene would seem counterproductive. We developed a trea...
Saved in:
Main Authors: | Amanda W. K. AuYeung, Robert C. Mould, Ashley A. Stegelmeier, Jacob P. van Vloten, Khalil Karimi, J. Paul Woods, James J. Petrik, Geoffrey A. Wood, Byram W. Bridle |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/cc74d8086b614168938f0bb79a7adef3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.
by: Raquel Garijo, et al.
Published: (2014) -
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
by: Marie-Claude Bourgeois-Daigneault, et al.
Published: (2021) -
Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections
by: Robert C. Mould, et al.
Published: (2017) -
Correction: In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity
Published: (2021) -
Structure of the vesicular stomatitis virus N⁰-P complex.
by: Cédric Leyrat, et al.
Published: (2011)